Author Archives: Pablo Ortiz

<span property="name">Pablo Ortiz</span>
Pablo Ortiz graduated in Pharmacy from the University of the Basque Country (UPV/EHU) and received an MSc in Synthetic and Industrial Chemistry from the same university. He then moved to the Netherlands where he received a PhD in Synthetic Organic Chemistry from the University of Groningen. He is currently biopolymer and bioaromatics researcher at the Belgium Institute for Technological Research (Vito)

Turning simple, individual molecules into complex, interconnected materials is the core of polymer chemistry. There is currently an increasing demand for materials with sophisticated properties such as self-healing and reusable adhesivity. However, achieving polymers with such functionalities generally demands higher […]

Both the depletion of fossil fuels and the environmental concerns are a powerful drive for the development of sustainable routes to commodity chemicals. Lignocellulose, comprised of lignin, cellulose and hemicellulose, is the ideal candidate, but its inherent complexity hampers its […]

Organic chemistry is the science and the art of making carbon containing molecules. In these, carbon atoms may be linked by a single, double or triple bond to another carbon atom. Bonds are not more than the way we humans […]

This year the Nobel Prize in Chemistry has been awarded to Jean-Pierre Sauvage, Fraser Stoddart and Ben Feringa “for the design and synthesis of molecular machines”. These devices, often described as the tiniest “Lego”, are indeed so small that […]

Organic small molecules are essential for many different fields, from medicine to technology: Most of the drugs we take, biological probes and the constituents of solar cells, to name but a few, are small organic molecules. (Figure 1)
However, their […]

 
There is a widespread concern about the increasing antibiotic resistance and the limited new drugs to treat infectious diseases, as discussed in a previous post. Consequently, the discovery of a new antibiotic active against a range of bacterial […]

The Ebola outbreak has brought the fear of a viral pandemic to the headlines once more, as it happened before with the avian or swine flu. Although viruses-caused infections catch most of attention on the media, the greatest risk to […]

The discovery and development of new drugs is a long and expensive process, and despite of it, essential to face present and new diseases. For small molecules, which account for the majority of the marketed drugs, the discovery process generally […]